PLIN4 | Perilipin 4 | Plasma proteins
| | | | | Tissue enriched |
LRG1 | Leucine-rich alpha-2-glycoprotein 1 | Plasma proteins Predicted secreted proteins
| | | | | Tissue enriched |
C19orf10 | Chromosome 19 open reading frame 10 | Plasma proteins Predicted secreted proteins
| | | | | Expressed in all |
DPP9 | Dipeptidyl-peptidase 9 | Enzymes
| | | | | Expressed in all |
TICAM1 | Toll-like receptor adaptor molecule 1 | Disease related genes
| | | | | Expressed in all |
PLIN3 | Perilipin 3 | FDA approved drug targets Plasma proteins
| | | | | Expressed in all |
SAFB2 | Scaffold attachment factor B2 | Plasma proteins
| | | | | Expressed in all |
SAFB | Scaffold attachment factor B | Plasma proteins
| | | | | Expressed in all |
RPL36 | Ribosomal protein L36 | Ribosomal proteins
| | | | | Expressed in all |
LONP1 | Lon peptidase 1, mitochondrial | Enzymes Mitochondrial proteins
| | | | | Expressed in all |
PRR22 | Proline rich 22 | | | | | | Tissue enriched |
CAPS | Calcyphosine | | | | | | Tissue enriched |
RANBP3 | RAN binding protein 3 | Cancer-related genes
| | | | | Expressed in all |
ACSBG2 | Acyl-CoA synthetase bubblegum family member 2 | Enzymes Predicted membrane proteins
| | | | | Tissue enriched |
MLLT1 | Myeloid/lymphoid or mixed-lineage leukemia (trithorax homolog, Drosophila); translocated to, 1 | Cancer-related genes Disease related genes
| | | | | Expressed in all |
CLPP | Caseinolytic mitochondrial matrix peptidase proteolytic subunit | Disease related genes Enzymes Mitochondrial proteins Potential drug targets
| | | | | Expressed in all |
ALKBH7 | AlkB, alkylation repair homolog 7 (E. coli) | | | | | | Expressed in all |
GTF2F1 | General transcription factor IIF, polypeptide 1, 74kDa | Plasma proteins
| | | | | Expressed in all |
KHSRP | KH-type splicing regulatory protein | Plasma proteins
| | | | | Expressed in all |
CRB3 | Crumbs homolog 3 (Drosophila) | Predicted membrane proteins
| | | | | Mixed |
DENND1C | DENN/MADD domain containing 1C | | | | | | Mixed |
TUBB4A | Tubulin, beta 4A class IVa | Disease related genes Plasma proteins
| | | | | Group enriched |
C3 | Complement component 3 | Candidate cardiovascular disease genes Disease related genes FDA approved drug targets Plasma proteins Predicted secreted proteins
| | | | | Tissue enriched |
GPR108 | G protein-coupled receptor 108 | Predicted membrane proteins Predicted secreted proteins
| | | | | Expressed in all |
TRIP10 | Thyroid hormone receptor interactor 10 | Cytoskeleton related proteins Plasma proteins
| | | | | Expressed in all |
VAV1 | Vav 1 guanine nucleotide exchange factor | Plasma proteins
| | | | | Mixed |
INSR | Insulin receptor | CD markers Disease related genes Enzymes FDA approved drug targets Plasma proteins Predicted membrane proteins RAS pathway related proteins
| | | | | Expressed in all |
CTD-2207O23.3 | Rho guanine nucleotide exchange factor 18 | | | | | | Tissue enhanced |
ARHGEF18 | Rho/Rac guanine nucleotide exchange factor (GEF) 18 | | | | | | Expressed in all |
MCOLN1 | Mucolipin 1 | Disease related genes Potential drug targets Predicted membrane proteins Transporters Voltage-gated ion channels
| | | | | Expressed in all |
FCER2 | Fc fragment of IgE, low affinity II, receptor for (CD23) | Cancer-related genes CD markers Predicted membrane proteins
| | | | | Group enriched |
CLEC4G | C-type lectin domain family 4, member G | Predicted membrane proteins
| | | | | Group enriched |
CD209 | CD209 molecule | CD markers Predicted membrane proteins
| | | | | Mixed |
CLEC4M | C-type lectin domain family 4, member M | CD markers Predicted membrane proteins
| | | | | Group enriched |
EVI5L | Ecotropic viral integration site 5-like | Predicted membrane proteins
| | | | | Expressed in all |
MAP2K7 | Mitogen-activated protein kinase kinase 7 | Enzymes Plasma proteins
| | | | | Expressed in all |
SNAPC2 | Small nuclear RNA activating complex, polypeptide 2, 45kDa | | | | | | Expressed in all |
TIMM44 | Translocase of inner mitochondrial membrane 44 homolog (yeast) | Mitochondrial proteins Plasma proteins
| | | | | Expressed in all |
ELAVL1 | ELAV like RNA binding protein 1 | Plasma proteins
| | | | | Expressed in all |
RPS28 | Ribosomal protein S28 | Ribosomal proteins
| | | | | Expressed in all |
MARCH2 | Membrane-associated ring finger (C3HC4) 2, E3 ubiquitin protein ligase | Predicted membrane proteins
| | | | | Expressed in all |
HNRNPM | Heterogeneous nuclear ribonucleoprotein M | Plasma proteins
| | | | | Expressed in all |
MBD3L1 | Methyl-CpG binding domain protein 3-like 1 | | | | | | Group enriched |
MUC16 | Mucin 16, cell surface associated | Predicted membrane proteins
| | | | | Tissue enhanced |
ZNF317 | Zinc finger protein 317 | Transcription factors
| | | | | Expressed in all |
ZNF266 | Zinc finger protein 266 | Transcription factors
| | | | | Expressed in all |
PIN1 | Peptidylprolyl cis/trans isomerase, NIMA-interacting 1 | Cancer-related genes Enzymes
| | | | | Expressed in all |
COL5A3 | Collagen, type V, alpha 3 | Cancer-related genes Predicted secreted proteins
| | | | | Mixed |
EIF3G | Eukaryotic translation initiation factor 3, subunit G | Plasma proteins
| | | | | Expressed in all |
DNMT1 | DNA (cytosine-5-)-methyltransferase 1 | Disease related genes Enzymes FDA approved drug targets Plasma proteins Transcription factors
| | | | | Expressed in all |